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contrast	bright	cells	are	an	indication	of	viability	and	intact	membrane.		In	contrast,	
supernatants	from	macrophages	not	exposed	to	apoptotic	cells	that	were	in	the	absence	of	
serum	supplement,	did	not	support	Oli-neu	cells	after	48	hrs	as	shown	in	phase	contrast	dim	
cells	(Figure	1C).		Here,	the	majority	of	OPCs	in	the	control	wells	were	dead.		After	
quantification	of	these	cells,	no	significant	differences	were	observed	between	cells	stimulated	
with	wild-type	and	mertk-/-	macrophage	supernatants.		Though,	significant	differences	were	
observed	between	cells	stimulated	with	macrophage	supernatants	as	opposed	to	
unconditioned	RPMI.		Cells	stimulated	with	macrophage	supernatants	demonstrate	higher	
levels	of	viable	cells	and	lower	levels	of	dead	cells.		This	suggests	that	factors	secreted	from	
macrophages	exposed	to	apoptotic	cells	provide	nutritional	support	of	Oli-neu	cells.		There	data	
are	consistent	with	the	notion	that	macrophages	may	be	providing	OPCs	with	extracellular	
factors	that	induce	activation,	growth,	and	differentiation.	
Figure	4:	This	diagram	demonstrates	the	number	of	proteins	differentially	expressed	in	wild-
type	and	mertk-/-	macrophage	supernatants.		Proteins	expressed	by	wild-type	macrophages	at	
two	fold	or	greater	concentrations	as	compared	to	mertk-/-	macrophages	were	placed	in	the	
wild-type	macrophage	supernatant	category.		The	same	was	done	for	proteins	expressed	at	two	
fold	or	greater	concentrations	by	the	mertk-/-	macrophages.		Those	proteins	that	were	
expressed	at	similar	levels	were	placed	in	the	overlapping	area.			
	 	
	 Proteomic	analysis	of	supernatants	showed	that	111	proteins	were	expressed	at	a	two-
fold	or	greater	concentration	in	wild-type	macrophage	supernatants	and	88	proteins	were	
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expressed	at	a	two-fold	or	greater	concentrations	in	mertk-/-	macrophage	supernatants.		355	
proteins	were	found	to	be	expressed	in	similar	concentration	between	the	two	types	of	
supernatants.		As	wild-type	macrophages	induce	higher	levels	of	differentiation	of	OPCs,	the	
differentiation	factor	is	assumed	to	be	found	in	the	111	proteins	expressed	at	higher	levels	
from	wild-type	macrophages.			
	
Discussion	
This	study	aimed	to	find	evidence	for	cell	signaling	between	macrophages	and	OPCs.		
Activin	A	is	a	growth	factor	that	is	a	part	of	the	TGF	superfamily	and	is	known	to	support	
proliferation	of	various	undifferentiated	stem	cells	(Natale).		Along	with	macrophages,	it	has	
also	been	associated	with	acute	CNS	tissue	injury	and	inflammation	(Wilms)	thereby	making	it	
an	ideal	macrophage	target	signal	for	remyelination	studies	as	neuroinflammation	is	a	symptom	
of	many	demyelinating	diseases.		Results	show	that	supernatants	from	macrophages	in	WT	
mice	stimulated	with	apoptotic	thymocytes	increase	OPC	differentiation	and	allow	for	cell	
survival,	suggesting	that	a	secreted	signal	from	macrophages	can	influence	OPCs.			
Supernatants	from	wild-type	macrophages	(mertk+/+)	produced	a	greater	proportion	of	
cells	with	higher	level	differentiation,	which	suggests	that	a	signal	going	through	the	Mertk	
pathway	is	responsible	for	increased	differentiation	in	OPCs.		This	signal	must	be	one	that	is	
secreted	by	the	macrophages,	rather	than	a	cell	membrane	component,	because	the	
supernatant	was	spun	in	a	tabletop	centrifuge	forcing	any	cells	or	cell	debris	to	the	bottom	of	
the	tube,	preventing	transfer	to	the	subsequent	tube.		Therefore,	instead	of	direct	contact	
between	macrophages	and	OPCs	through	intermembrane	proteins,	the	signal	is	produced	by	a	
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secreted	factor	remaining	in	the	supernatant.		Not	only	is	this	signal	secreted,	but	this	study	
also	suggests	that	there	is	a	higher	quantity	of	this	signal	in	24-hour	supernatants	as	opposed	to	
0,	6,	and	12-hour	supernatants.			
One	potential	secreted	factor	that	is	known	to	induce	differentiation	in	several	cell	types	
is	Activin	A.		Previous	unpublished	data	from	the	Matsushima	lab	has	suggested	that	Activin	A	
may	be	a	component	of	the	Mertk	pathway,	reaching	peak	secretion	24	hours	after	stimulation	
with	apoptotic	cells.	These	characteristics	of	Activin	A	align	with	observed	results	from	this	
experiment,	supporting	the	hypothesis	that	Activin	A	is	positively	regulating	differentiation	of	
OPCs.		Although	these	experiments	do	not	prove	that	Activin	A	is	solely	responsible	for	OPC	
differentiation,	additional	experiments	could	be	conducted	to	determine	whether	Activin	A	is	
present	in	these	cultures	and	functions	to	induce	OPC	differentiation,	so	as	to	determine	cause	
and	effect.		We	attempted	to	conduct	such	experiments	but	they	were	difficult	to	execute	due	
to	reduced	robustness	of	our	Oli-neu	differentiation	assay.		Furthermore,	mertk-/-	macrophages	
should	not	be	able	to	clear	apoptotic	cells	by	phagocytosis	and	therefore	would	not	produce	
Activin	A	to	induce	differentiation.		However,	some	Oli-neu	cells	treated	with	mertk-/-		
macrophage	supernatants	were	able	to	obtain	higher	levels	of	differentiation,	suggesting	the	
cell	line	changed	properties	or	that	other	factors	may	be	contributing	to	OPC	maturation	as	
well.				
	 Additionally,	supernatants	from	both	wild-type	and	mertk-/-	mice	allowed	for	increased	
survival	of	OPCs.		This	suggests	that	both	supernatants	contained	a	survival	factor	that	allows	
OPCs	to	better	adjust	to	stressful	environments.		Mertk-/-	supernatants	seem	to	produce	OPCs	
will	similar	survival	levels	to	wild-type	supernatants,	indicating	that	the	unknown	survival	factor	
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in	question	is	not	regulated	through	the	Mertk	pathway.		Similar	to	the	differentiating	factor	
mentioned	above,	this	signal	seems	to	be	one	that	is	secreted	as	it	was	carried	in	the	
macrophage	supernatants.			
It	was	not	surprising	to	see	primary	differentiation	within	the	control	group	that	
received	no	supernatants,	as	the	cell	line	was	immortalized	during	a	stage	in	which	the	OPCs	
had	a	bipolar	morphology.		This	bipolar	morphology	is	consistent	with	the	control	results	and	its	
presence	in	other	experimental	wells.			However,	in	this	experiment	and	a	previous	experiment	
not	shown,	there	were	greater	numbers	of	Oli-neu	cells	with	tertiary	morphology	exposed	to	
supernatants	from	wild	type	macrophages	suggesting	that	remyelination	may	be	partly	
dependent	on	the	presence	of	myeloid	cells.		It	remains	to	be	seen	whether	microglia	replicate	
a	similar	function	in	generating	factors	that	promotes	OPC	differentiation.		This	is	an	important	
concept	to	pursue	with	further	experimentation	because	histopathology	of	lesions	from	MS	
brains	suggest	there	is	a	lack	of	differentiation	of	OPCs.						
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